Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Boots could be spun out if Walgreens buyout goes ahead - report

(Sharecast News) - Chemist chain Boots could be put up for sale again should a possible takeover of its US parent go ahead, it was reported on Wednesday. The UK retailer is part of Walgreens Boots Alliance, which is understood to be in talks with US private equity firm Sycamore Partners, a specialist in retail assets.

Walgreens has around 12,500 outlets in the US, Europe and South America. But it has been rocked by high inflation and stiff competition, and slumped to a $8.6bn loss in the most recent fiscal year.

It has already announced plans to shut stores, but according to multiple media reports, including the Financial Times and Wall Street Journal, it is now in potential takeover talks with Sycamore.

The New York-listed retailer currently has a market value of around $8bn.

However, according to Sky News, Sycamore will likely spin off Boots if it succeeds in taking Walgreens private.

The 175-year Nottingham-based retailer, which has around 1,900 stores and employs 52,000 people, was acquired by Walgreens in 2014.

Previous owner Stefano Pessina, the veteran Italian dealmaker who orchestrated the sale to Walgreens, retains a 17% stake and is likely to be a potential bidder should it come to market, Sky News noted.

Pessina combined Boots with his own pharmacy business in 2006 to create Alliance Boots, before teaming up with US private equity firm KKK to take the then blue chip private. Walgreens took an initial 45% stake before buying Boots outright.

Private equity firms are also likely to be interested, however, including Apollo Global Management.

A number were understood to be interested in 2022, when Walgreens was last considering selling Boots. Apollo and India's Reliance Industries were understood to be putting together a possible £5bn joint offer when Walgreens terminated the sale process.

So far neither Pessina, Walgreens nor Sycamore have commented.

Share this article

Related Sharecast Articles

Eden Research revenue rises, losses set to widen
(Sharecast News) - Sustainable biopesticide and biocontrol technology specialist Eden Research reported significant revenue growth for the year ended 31 December on Monday, alongside a positive outlook for 2025.
Macy's trims Q4 sales outlook, shares dip
(Sharecast News) - US department store Macy's slightly downgraded its sales outlook for the fourth quarter after a quieter-than-expected Christmas period.
Canaccord starts coverage of Science Group at 'buy'
(Sharecast News) - Canaccord Genuity started coverage of Science Group on Monday with a 'buy' rating and 758p price target as it pointed to 14 years of strong shareholder returns.
Berenberg raises target price on Dalata Hotel Group following CMD event
(Sharecast News) - Analysts at Berenberg raised their target price on Irish hotel operator Dalata Hotel Group from 480.0p to 510.0p on Monday following the company's recent Capital Markets Day.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.